Chapter 1. MEDICAL IMAGING REAGENTS MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. MEDICAL IMAGING REAGENTS MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-110 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. MEDICAL IMAGING REAGENTS MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. MEDICAL IMAGING REAGENTS MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. MEDICAL IMAGING REAGENTS MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. MEDICAL IMAGING REAGENTS MARKET– By Product Type

6.1. Contrast Reagents

6.2. Optical Reagents

6.3. Nuclear Reagents

Chapter 7. MEDICAL IMAGING REAGENTS MARKET– By Modality

7.1. Computed Tomography (CT)

7.2. Magnetic Resonance Imaging (MRI)

7.3. Ultrasound

7.4. X-Ray

7.5. Single Photon Emission Computed Tomography (SPECT)

7.6. Others

Chapter 8. MEDICAL IMAGING REAGENTS MARKET– By Application

8.1. Oncology

8.2. Cardiology

8.3. Neurology

8.4. Gastroenterology

8.5. Orthopedics

8.6. Others

Chapter 9. MEDICAL IMAGING REAGENTS MARKET– By Region

9.1. North America

9.2. Europe

9.3. The Asia Pacific

9.4. Latin America

9.5. Middle-East and Africa

Chapter 10. MEDICAL IMAGING REAGENTS MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company 8

10.9. Company 9

10.10. Company 10

Download Sample